ANTI-TUBERCULOSIS DRUGS USED IN COMBINATIONS

被引：0
|
作者：
不详
机构：
来源：
HSMHA HEALTH REPORTS | 1971年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：896 / &
相关论文
共 50 条
  • [1] ITRACONAZOLE AND ANTI-TUBERCULOSIS DRUGS
    BLOMLEY, M
    TEARE, EL
    DEBELDER, A
    THWAY, Y
    WESTON, M
    [J]. LANCET, 1990, 336 (8725): : 1255 - 1255
  • [2] HEPATOTOXICITY BY ANTI-TUBERCULOSIS DRUGS
    Yanez Elena, Sanchez
    Maria Rosa, Mora Santiago
    Jose Manuel, Fernandez Ovies
    [J]. ATENCION FARMACEUTICA, 2011, 13 (06): : 338 - +
  • [3] TESTING ANTI-TUBERCULOSIS DRUGS
    不详
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1952, 2 (4799): : 1402 - 1403
  • [4] The epidemiology of tuberculosis and resistance to anti-tuberculosis drugs
    Khaled, NA
    Enarson, D
    Billo, N
    [J]. REVUE DES MALADIES RESPIRATOIRES, 1997, 14 : S8 - S18
  • [5] Potentiating the Anti-Tuberculosis Efficacy of Peptide Nucleic Acids through Combinations with Permeabilizing Drugs
    Cotta, Karishma Berta
    Ghosh, Saptarshi
    Mehra, Sarika
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (01):
  • [6] Cause Of Anti-Tuberculosis Drugs Discontinuation
    Ohashi, K.
    Takamori, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [7] PREMATURE EJACULATION WITH ANTI-TUBERCULOSIS DRUGS
    Chityala, Surendra K.
    [J]. RESPIROLOGY, 2013, 18 : 40 - 40
  • [8] Delayed hypersensitivity to anti-tuberculosis drugs
    Tetart, F.
    [J]. REVUE FRANCAISE D ALLERGOLOGIE, 2020, 60 (04): : 248 - 249
  • [9] ACTIVITY AND EFFECTIVENESS OF ANTI-TUBERCULOSIS DRUGS
    GROSSET, J
    [J]. LYON MEDICAL, 1979, 241 (09): : 567 - 573
  • [10] Surveillance of Anti-tuberculosis Drugs in Thailand
    Sriphiromya, P.
    Suwankesawong, W.
    [J]. DRUG SAFETY, 2018, 41 (11) : 1262 - 1263
12345